Purpose: To assess long-term functional outcome and survival among patients with
meningioma World Health Organization (WHO) grade I. Methods: Retrospective analysis of …

Object The authors conducted a study to determine population-based estimates of survival
following the diagnosis and treatment of nonmalignant intracranial meningioma in the US in …

Meningiomas represent one of the largest subgroups of intracranial tumors. They are
generally benign, but may show a histological progression to malignancy. Grades II and III …

Purpose: Meningiomas are the commonest predominantly non-malignant brain tumour in
adults. The use of surgery appears to be increasing, and outcomes are thought to be good …

Object. To explore factors affecting the survival rate in patients with meningiomas, the
authors used the National Cancer Data Base (NCDB), which includes tumors from …

The purpose of this study is to summarize our experience in managing patients with an
atypical or malignant meningioma at our institution, with a specific focus on determining the …

OBJECTIVE Patients with atypical and malignant (WHO Grade II and III) meningiomas have
a worse prognosis than patients with benign (WHO Grade I) meningiomas. However, there is …

Intracranial meningioma was diagnosed and histologically verified in 1986 patients, 597
men and 1389 women, between 1953 and 1984 in Finland. The closing date of this survival …

Object Despite a favorable outcome for most patients with WHO Grade I meningiomas, a
subset of these patients will have recurrent or progressive disease that advances to a higher …

To analyse the outcome of patients with WHO grade II meningioma and identify factors that
may influence recurrence and survival. Between January 2007 and September 2015, a …